Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Louis Terriou, Zina Chir, Helene Esperou, Jean-Michel Boiron, Jean-Paul Vernant, Nicole Gratecos, Mauricette Michalet, Noel Milpied, Jean-Pierre Jouet, Ibrahim Yakoub-Agha, Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire

Blood (2007) 110 (11): 4924.

https://doi.org/10.1182/blood.V110.11.4924.4924

Published: 2007

Journal Articles

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Andrea Toma, Marie-Lorraine Balere-Appert, Zina Chir, Jean-Michel Boiron, Pierre Bordigoni, Gerard Socie, Jean-Paul Vernant, Marc Renaud, Noel-Jean Milpied, Mauricette Michallet, Eric Deconninck, Denis Guyotat, Frederic Garban, Anne Sirvent, Nathalie Contentin, Didier Blaise, Colette Raffoux, Agnes Buzyn

Blood (2006) 108 (11): 3149.

https://doi.org/10.1182/blood.V108.11.3149.3149

Published: 2006

Journal Articles

Unrelated Allogeneic Stem Cell Transplantation for Severe Acquired Aplastic Anemia: Has Outcome Improved?.

Sebastien Maury, M.-Lorraine Balere-Appert, Zina Chir, J.-Michel Boiron, Claire Galambrun, Karima Yakouben, Pierre Bordigoni, Aude Marie-Cardine, Noel Milpied, Justina Kanold, Natacha Maillard, J.-Henri Bourhis, Alain Fischer, Patrick Lutz, Mauricette Michallet, Didier Blaise, Catherine Cordonnier, Colette Raffoux, Gerard Socie

Blood (2006) 108 (11): 3105.

https://doi.org/10.1182/blood.V108.11.3105.3105

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed/Refractory T Cell Lymphomas in Adults: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Steven Le Gouill, Jean-noël Milpied, Jean-paul Vernant, Norbert Ifrah, Françoise Mechinaud, Nicole Gratecos, Zina Chir, Jean-luc Harousseau, Gérard Socié, Corinne Haioun, Didier Blaise, Mauricette Michallet

Blood (2006) 108 (11): 3020.

https://doi.org/10.1182/blood.V108.11.3020.3020

Published: 2006

Journal Articles

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

Anne Sirvent, MD, Michael Hummelsberger, MD, Zina Chir, Nathalie Dhedin, MD, Catherine Faucher, MD, Jean-Pierre Jouet, MD, Michel Attal, MD, Patrice Chevalier, MD, Marie Robin, MD, Reza Tabrizi, MD, Pierre Bordigoni, MD, Jean-Henri Bourhis, MD, Agnes Buzyn, MD, Nathalie Contentin, MD, Jerome Cornillon, MD, Frederic Garban, MD, Mauricette Michallet, MD

Blood (2006) 108 (11): 2946.

https://doi.org/10.1182/blood.V108.11.2946.2946

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Didier Blaise, Zina Chir, Michel Attal, Jean-Henri Bourhis, Jean-Jacques Sotto, Jean-Michel Boiron, Noel Milpied, Jean-Yves Cahn, Bernard Rio, Bruno Lioure, Francois Guilhot, C. Berthou, Agnes Buzyn, Mauricette Michallet

Blood (2005) 106 (11): 1140.

https://doi.org/10.1182/blood.V106.11.1140.1140

Published: 2005

Journal Articles

Is Antilymphocyte Globulin Useful in Conditioning Regimen of Unrelated Donor Hematopoïetic Stem Cell Transplantation?.

Helene Esperou, MD, Marie Lorraine Appert, MD, Ibrahim Yacoub Agha, MD, Noel Milpied, MD, Norbert Ifrah, MD, Mathieu Kuentz, MD, Zina Chir, Colette Raffoux, MD

Blood (2005) 106 (11): 2067.

https://doi.org/10.1182/blood.V106.11.2067.2067

Published: 2005

NARROW

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Unrelated Allogeneic Stem Cell Transplantation for Severe Acquired Aplastic Anemia: Has Outcome Improved?.

Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed/Refractory T Cell Lymphomas in Adults: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Is Antilymphocyte Globulin Useful in Conditioning Regimen of Unrelated Donor Hematopoïetic Stem Cell Transplantation?.

Email alerts

ASH Publications

American Society of Hematology

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Unrelated Allogeneic Stem Cell Transplantation for Severe Acquired Aplastic Anemia: Has Outcome Improved?.

Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed/Refractory T Cell Lymphomas in Adults: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Is Antilymphocyte Globulin Useful in Conditioning Regimen of Unrelated Donor Hematopoïetic Stem Cell Transplantation?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only